4 reactions
New partial reprogramming result from Altos Labs: the Belmonte group reports a ~12% overall lifespan increase — equivalent to a ~38% increase in remaining lifespan after the start of therapy at 18 months — in normal mice via a Cdkn2a-OSK gene therapy:
#science
#science
| 15,000 mlx | |
| 11 | |
| 4 |